EcoR1 Capital, LLC Q2 2018 Filing
Filed August 14, 2018
Portfolio Value
$1.1T
Holdings
33
Report Date
Q2 2018
Filing Type
13F-HR
All Holdings (33 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | FGENEURFIBROGEN INC | 2,017,250 | $126.3B | 12.02% | |
| 2 | IRWDIRONWOOD PHARMACEUTICALS INC | 6,250,073 | $119.5B | 11.38% | |
| 3 | ASMBASSEMBLY BIOSCIENCES INC | 2,943,164 | $115.4B | 10.99% | |
| 4 | ASNDASCENDIS PHARMA A S | 1,464,067 | $97.4B | 9.27% | |
| 5 | KURAKURA ONCOLOGY INC | 3,904,675 | $71.1B | 6.77% | |
| 6 | MDGLMADRIGAL PHARMACEUTICALS INC | 199,500 | $55.8B | 5.31% | |
| 7 | —CELGENE CORP | 585,000 | $46.5B | 4.42% | Call |
| 8 | SRRKSCHOLAR ROCK HLDG CORP | 2,671,161 | $41.7B | 3.97% | |
| 9 | —DICERNA PHARMACEUTICALS INC | 2,961,147 | $36.3B | 3.45% | |
| 10 | MGNXMACROGENICS INC | 1,450,606 | $30.0B | 2.85% | |
| 11 | ASNDASCENDIS PHARMA A S | 447,000 | $29.7B | 2.83% | Call |
| 12 | RCUSARCUS BIOSCIENCES INC | 2,236,387 | $27.4B | 2.61% | |
| 13 | —UNITY BIOTECHNOLOGY INC | 1,680,644 | $25.3B | 2.41% | |
| 14 | KZRKEZAR LIFE SCIENCES INC | 1,272,198 | $22.0B | 2.10% | |
| 15 | —FIBROGEN INC | 350,000 | $21.9B | 2.09% | Call |
| 16 | GBYSANGAMO THERAPEUTICS INC | 1,509,671 | $21.4B | 2.04% | |
| 17 | —MAGENTA THERAPEUTICS INC | 1,538,088 | $20.8B | 1.98% | |
| 18 | GILDGILEAD SCIENCES INC | 292,600 | $20.7B | 1.97% | Call |
| 19 | —IMMUNE DESIGN CORP | 4,437,600 | $20.2B | 1.92% | |
| 20 | WVEWAVE LIFE SCIENCES LTD | 412,871 | $15.8B | 1.50% | |
| 21 | SURFUSDSURFACE ONCOLOGY INC | 890,808 | $14.5B | 1.38% | |
| 22 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 1,039,500 | $12.7B | 1.21% | |
| 23 | IRWDIRONWOOD PHARMACEUTICALS INC | 577,600 | $11.0B | 1.05% | Call |
| 24 | —ACHILLION PHARMACEUTICALS INC | 3,887,407 | $11.0B | 1.05% | |
| 25 | —KADMON HLDGS INC | 2,500,000 | $10.0B | 0.95% | |
| 26 | —ASSEMBLY BIOSCIENCES INC | 148,100 | $5.8B | 0.55% | Call |
| 27 | —DBV TECHNOLOGIES S A | 298,100 | $5.8B | 0.55% | |
| 28 | CRVSCORVUS PHARMACEUTICALS INC | 450,400 | $4.9B | 0.47% | |
| 29 | —AQUINOX PHARMACEUTICALS INC | 1,150,000 | $3.0B | 0.29% | |
| 30 | —ONCONOVA THERAPEUTICS INC | 7,500,000 | $3.0B | 0.29% | |
| 31 | ERYP1EURERYTECH PHARMA | 153,964 | $1.7B | 0.17% | |
| 32 | —APTINYX INC | 41,037 | $992.0M | 0.09% | |
| 33 | INFIQINFINITY PHARMACEUTICALS INC | 412,000 | $787.0M | 0.07% |